| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 化学药品制剂(元) | 56,044,691.74 | - | 61,846,347.67 | - | 215,303,621.38 |
| 抗流感病毒类药物(元) | - | 88,037,904.07 | - | 197,672,227.82 | - |
| 抗生素类药物(元) | - | 30,192,405.06 | - | 44,601,885.91 | - |
| 心血管类药物(元) | - | 23,581,858.40 | - | 20,986,672.52 | - |
| 解热镇痛类药物(元) | - | 106,941.45 | - | - | - |
| 营业成本(元) | |||||
| 化学药品制剂(元) | 47,639,833.95 | - | 36,563,058.10 | - | 78,192,362.12 |
| 抗流感病毒类药物(元) | - | 47,627,452.28 | - | 58,346,322.82 | - |
| 抗生素类药物(元) | - | 38,019,835.19 | - | 51,847,432.35 | - |
| 心血管类药物(元) | - | 11,480,870.57 | - | 9,361,290.58 | - |
| 解热镇痛类药物(元) | - | 87,626.75 | - | - | - |
| 毛利(元) | |||||
| 化学药品制剂(元) | 8,404,857.79 | - | 25,283,289.57 | - | 137,111,259.26 |
| 抗流感病毒类药物(元) | - | 40,410,451.79 | - | 139,325,905.00 | - |
| 抗生素类药物(元) | - | -7,827,430.13 | - | -7,245,546.44 | - |
| 心血管类药物(元) | - | 12,100,987.83 | - | 11,625,381.94 | - |
| 解热镇痛类药物(元) | - | 19,314.70 | - | - | - |
| 毛利率(%) | |||||
| 化学药品制剂(%) | 15.00 | - | 40.88 | - | 63.68 |
| 抗流感病毒类药物(%) | - | 45.90 | - | 70.48 | - |
| 抗生素类药物(%) | - | -25.93 | - | -16.24 | - |
| 心血管类药物(%) | - | 51.31 | - | 55.39 | - |
| 解热镇痛类药物(%) | - | 18.06 | - | - | - |
| 收入构成(%) | |||||
| 化学药品制剂(%) | 100.00 | - | 100.00 | - | 100.00 |
| 抗流感病毒类药物(%) | - | 62.03 | - | 75.09 | - |
| 抗生素类药物(%) | - | 21.27 | - | 16.94 | - |
| 心血管类药物(%) | - | 16.62 | - | 7.97 | - |
| 解热镇痛类药物(%) | - | 0.08 | - | - | - |
| 毛利构成(%) | |||||
| 化学药品制剂(%) | 100.00 | - | 100.00 | - | 100.00 |
| 抗流感病毒类药物(%) | - | 90.40 | - | 96.95 | - |
| 抗生素类药物(%) | - | -17.51 | - | -5.04 | - |
| 心血管类药物(%) | - | 27.07 | - | 8.09 | - |
| 解热镇痛类药物(%) | - | 0.04 | - | - | - |